It is worth noting that regarding chronic HCC treatment, Ex-4 did not allow tumor cell regrowth by preventing some resistance mechanisms that the cells can acquire, while it exhibited greater capability to inhibit tumor proliferation than liraglutide, another GLP-1R analogue (Table 2). Here, GLP1R is linked to neoplasm.